IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v19y2022i23p15697-d984205.html
   My bibliography  Save this article

The Validity of Benchmark Dose Limit Analysis for Estimating Permissible Accumulation of Cadmium

Author

Listed:
  • Soisungwan Satarug

    (Kidney Disease Research Collaborative, Translational Research Institute, Brisbane 4102, Australia)

  • David A. Vesey

    (Kidney Disease Research Collaborative, Translational Research Institute, Brisbane 4102, Australia
    Department of Nephrology, Princess Alexandra Hospital, Brisbane 4102, Australia)

  • Glenda C. Gobe

    (Kidney Disease Research Collaborative, Translational Research Institute, Brisbane 4102, Australia
    School of Biomedical Sciences, The University of Queensland, Brisbane 4072, Australia
    NHMRC Centre of Research Excellence for CKD QLD, UQ Health Sciences, Royal Brisbane and Women’s Hospital, Brisbane 4029, Australia)

  • Aleksandra Buha Đorđević

    (Department of Toxicology “Akademik Danilo Soldatović”, Faculty of Pharmacy, University of Belgrade, 11000 Belgrade, Serbia)

Abstract

Cadmium (Cd) is a toxic metal pollutant that accumulates, especially in the proximal tubular epithelial cells of kidneys, where it causes tubular cell injury, cell death and a reduction in glomerular filtration rate (GFR). Diet is the main Cd exposure source in non-occupationally exposed and non-smoking populations. The present study aimed to evaluate the reliability of a tolerable Cd intake of 0.83 μg/kg body weight/day, and its corresponding toxicity threshold level of 5.24 μg/g creatinine. The PROAST software was used to calculate the lower 95% confidence bound of the benchmark dose (BMDL) values of Cd excretion (E Cd ) associated with injury to kidney tubular cells, a defective tubular reabsorption of filtered proteins, and a reduction in the estimated GFR (eGFR). Data were from 289 males and 445 females, mean age of 48.1 years of which 42.8% were smokers, while 31.7% had hypertension, and 9% had chronic kidney disease (CKD). The BMDL value of E Cd associated with kidney tubular cell injury was 0.67 ng/L of filtrate in both men and women. Therefore, an environmental Cd exposure producing E Cd of 0.67 ng/L filtrate could be considered as Cd accumulation levels below which renal effects are likely to be negligible. A reduction in eGFR and CKD may follow when E Cd rises from 0.67 to 1 ng/L of filtrate. These adverse health effects occur at the body burdens lower than those associated with E Cd of 5.24 µg/g creatinine, thereby arguing that current health-guiding values do not provide a sufficient health protection.

Suggested Citation

  • Soisungwan Satarug & David A. Vesey & Glenda C. Gobe & Aleksandra Buha Đorđević, 2022. "The Validity of Benchmark Dose Limit Analysis for Estimating Permissible Accumulation of Cadmium," IJERPH, MDPI, vol. 19(23), pages 1-15, November.
    • Handle: RePEc:gam:jijerp:v:19:y:2022:i:23:p:15697-:d:984205
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/19/23/15697/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/19/23/15697/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Yiliang Zhu & Tao Wang & Jenny Z.H. Jelsovsky, 2007. "Bootstrap Estimation of Benchmark Doses and Confidence Limits with Clustered Quantal Data," Risk Analysis, John Wiley & Sons, vol. 27(2), pages 447-465, April.
    2. Soisungwan Satarug & David A. Vesey & Glenda C. Gobe, 2022. "Dose–Response Analysis of the Tubular and Glomerular Effects of Chronic Exposure to Environmental Cadmium," IJERPH, MDPI, vol. 19(17), pages 1-14, August.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Alfred K. Mbah & Ibrahim Hamisu & Eknath Naik & Hamisu M. Salihu, 2014. "Estimating Benchmark Exposure for Air Particulate Matter Using Latent Class Models," Risk Analysis, John Wiley & Sons, vol. 34(11), pages 2053-2062, November.
    2. Walter W. Piegorsch & Hui Xiong & Rabi N. Bhattacharya & Lizhen Lin, 2014. "Benchmark Dose Analysis via Nonparametric Regression Modeling," Risk Analysis, John Wiley & Sons, vol. 34(1), pages 135-151, January.
    3. Signe M. Jensen & Felix M. Kluxen & Christian Ritz, 2019. "A Review of Recent Advances in Benchmark Dose Methodology," Risk Analysis, John Wiley & Sons, vol. 39(10), pages 2295-2315, October.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:19:y:2022:i:23:p:15697-:d:984205. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.